Macquarie University, North Ryde, NSW, 2109, Australia.
Advanced Neuropsychological Treatment Services, Strathfield South, NSW, 2136, Australia.
Neuropsychol Rev. 2022 Mar;32(1):161-191. doi: 10.1007/s11065-021-09506-3. Epub 2021 Apr 19.
Substance use disorders are associated with diverse neuropsychological impairments, with deficits in memory and executive functioning commonly observed. Cognitive remediation has been shown to be effective in other populations with cognitive impairments in these domains, including those with psychiatric disorders and acquired brain injuries, and it has been hypothesised to be similarly effective for those in treatment for substance use disorders. We aimed to systematically review the evidence for cognitive remediation interventions administered as an adjunct treatment to substance use rehabilitation. Studies were included if participants were receiving substance use treatment, if improving cognitive functioning was the main focus of the intervention and if they used an experimental design with a control condition receiving treatment-as-usual or an active control intervention. Two independent reviewers agreed on the final selection of 32 studies, encompassing cognitive remediation for working memory, memory, executive functioning and general cognition. Significant differences between intervention and control groups for cognitive test results and treatment outcomes were extracted and compared across treatment approaches. The review found considerable heterogeneity across studies, including in the types of interventions, the nature of participants and the outcome measures used. Further, a lack of quality studies with sufficient power meant that limited conclusions could be drawn, highlighting a need for further replication and research. However, findings indicate that cognitive remediation remains a promising potential avenue for improving cognition and treatment outcomes for those in treatment for substance use disorders. Protocol submitted prospectively to PROSPERO 30.09.2019, CRD42020150978.
物质使用障碍与多种神经认知障碍有关,常见的缺陷包括记忆和执行功能。认知矫正已被证明在其他领域存在认知障碍的人群中是有效的,包括精神障碍和获得性脑损伤患者,并且有人假设它对接受物质使用障碍治疗的患者同样有效。我们旨在系统地回顾作为物质使用康复辅助治疗的认知矫正干预的证据。如果参与者正在接受物质使用治疗、如果改善认知功能是干预的主要重点,并且如果他们使用了实验设计,包括接受常规治疗或积极对照干预的对照组,则将研究纳入。两名独立的审查员一致同意最终选择了 32 项研究,包括工作记忆、记忆、执行功能和一般认知的认知矫正。从认知测试结果和治疗结果中提取并比较了干预组和对照组之间的显著差异,并比较了不同的治疗方法。该综述发现,研究之间存在相当大的异质性,包括干预措施的类型、参与者的性质和使用的结果衡量标准。此外,由于缺乏质量足够高、有足够效力的研究,因此只能得出有限的结论,这突出表明需要进一步复制和研究。然而,研究结果表明,认知矫正仍然是改善接受物质使用障碍治疗的患者的认知和治疗结果的有前途的潜在途径。该方案于 2019 年 9 月 30 日前瞻性提交给 PROSPERO,注册号为 CRD42020150978。